Tag: Vaccines
New Sanofi-GSK COVID-19 Vaccine Highly Effective, Companies Say
In laboratory studies, two doses of the vaccine stimulated the production of more neutralizing antibodies than an approved mRNA vaccine
Low Risk Seen for Second Allergic Reaction to mRNA COVID-19 Vaccine
Of 1,366 patients with immediate allergic reaction to first dose, six developed severe immediate allergic reaction after second dose
Recommended Adult Immunization Schedule Updated for 2022
Changes include universal vaccination against hepatitis B for all adults aged 19 through 59 years and for at-risk older adults
Physician’s Briefing Weekly Coronavirus Roundup
Younger Moms Most Hesitant to Vaccinating Children Against COVID-19
Findings based on survey of Medicaid enrollees in Florida
COVID-19 Vaccination Safe During Pregnancy
No differences seen in neonatal and early infant outcomes for offspring exposed, not exposed to vaccine in utero
Humoral Response in Hemodialysis Patients Stronger With mRNA-1273
Antibody responses at six to seven and 12 weeks after the second dose stronger with mRNA-1273 versus BNT162b2
Vaccination in Pregnancy Prevents COVID-19 Hospitalization in Infants
Maternal completion of two-dose primary mRNA COVID-19 vaccination series 61 percent effective for preventing COVID-19 hospitalization
Antibodies Persist for Infants Born to COVID-19-Vaccinated Moms
Anti-spike antibody levels lower in infants born to mothers who were infected with SARS-CoV-2 at 20 to 32 weeks of gestation
Vaccine Effectiveness Up After Three COVID-19 Vaccine Doses
VE lower during omicron- versus delta-predominant period at all time points; waned with increasing time since vaccination
